Creating a database for cancer research and treatment
Official title: Development of a Monocentric and Prospective Clinical and Biological Database in Digestive Cancers, Gynecological Cancers, Breast Cancers and Sarcomas
Run by Institut du Cancer de Montpellier - Val d'Aurelle · NCT03449264 · Data updated 2026-11-12
This study is creating a detailed database to help researchers understand different types of cancer better and improve treatments for patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 4000 (estimated) |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle Academic / other |
| Locations | 1 site (Montpellier) |
| Status | Recruiting |
| Started | July 27, 2017 |
| Main results expected | November 2027 |
| Study ends | November 2037 |
| Registry record updated | February 12, 2025 |
| Trial ID | NCT03449264 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with invasive or in situ tumors of specific cancer types who are treatment-naïve and require surgical intervention.
✕Probably not a fit
Patients who are not affiliated with a social protection scheme or those unable to maintain regular follow-up due to various reasons may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to develop a comprehensive clinical and biological database to support research in various types of cancer, including digestive, gynecologic, breast cancer, and sarcoma. It focuses on collecting high-quality biological samples and clinical data to enhance understanding of tumor behavior and treatment responses. The initiative is part of a national health strategy to integrate research with clinical practice, ultimately benefiting patient care and advancing therapeutic innovations. By establishing a multidisciplinary framework, the project seeks to facilitate data sharing among researchers for improved cancer management.
Why it matters
Potential benefit: If successful, this initiative could lead to better prevention, diagnosis, and treatment strategies for various cancer types.
How similar studies have gone: Other studies have shown success in utilizing similar database approaches for cancer research, indicating a promising avenue for future advancements.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age\> at 18 years old, * Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded, * Patient in ICM at diagnosis * a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or * gynecological cancer (ovary, endometrium, cervix) or * breast cancer or * sarcoma. * Naïve patient of any treatment for the present cancer, * Patient requiring treatment involving at least one (or more) tumor surgery (s) * Patient who has accepted supplementary blood samples, * Patient having given his informed, written and express consent. Exclusion Criteria: * Patient not affiliated to a social protection scheme, * Patient whose regular follow-up is a priori impossible for psychological, familial, social or geographical reasons, * Pregnant and / or nursing women, * Subject under tutelage, curatorship or safeguard of justice, * Patient in an emergency situation.
Where it's running
-
Institut regional du Cancer - Val d Aurelle
Montpellier, France Recruiting
Study contacts
- Study coordinator: david azria
- Email: david.azria@icm.unicancer.fr
- Phone: +33467613102
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Riluzole to prevent thinking and memory problems during chemotherapy
This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.
-
Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues
This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.
-
Using blood tests to analyze tumor DNA in breast and digestive cancers
This study is testing whether blood tests that look for tumor DNA can help improve treatment and monitoring for people with breast, digestive, and gynecologic cancers.
-
Effects of Atezolizumab on Cancer Patients with Sensitive Tumor DNA or RNA
This study is testing if atezolizumab can help cancer patients with certain tumor types that show they might respond well to the treatment.
-
Personalized supervised exercise program for adults with breast or gynecologic cancer
A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.
-
Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers
This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.